TY - JOUR
T1 - Optic gliomas
T2 - Past, present, and future
AU - Miller, Neil R
PY - 2016
Y1 - 2016
N2 - Our understanding of the clinical presentation, natural history, and responses to therapy of OPGs, both ONGs and OCGs, is steadily increasing. At the same time, the molecular biology and genetics of these tumors are becoming increasingly clear in both NF1 and non-NF1 patients. It is to be hoped that an understanding of these issues hopefully will lead to molecular therapies (?gene therapy, ?nanoparticles) to prevent or treat these lesions.
AB - Our understanding of the clinical presentation, natural history, and responses to therapy of OPGs, both ONGs and OCGs, is steadily increasing. At the same time, the molecular biology and genetics of these tumors are becoming increasingly clear in both NF1 and non-NF1 patients. It is to be hoped that an understanding of these issues hopefully will lead to molecular therapies (?gene therapy, ?nanoparticles) to prevent or treat these lesions.
UR - http://www.scopus.com/inward/record.url?scp=84992734302&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84992734302&partnerID=8YFLogxK
U2 - 10.1097/WNO.0000000000000439
DO - 10.1097/WNO.0000000000000439
M3 - Article
C2 - 27798428
AN - SCOPUS:84992734302
SN - 1070-8022
VL - 36
SP - 460
EP - 473
JO - Journal of Neuro-Ophthalmology
JF - Journal of Neuro-Ophthalmology
IS - 4
ER -